Source comparison
Best BPC-157 Dosage Ligament Repair 2026: Protocol Comparison
Mild sprain, partial tear 250mcg daily Once daily Subcutaneous, <1cm from injury 3-4 weeks 50-60% reduction in recovery time versus unassisted healing Lowest effective dose; sufficient for grade I-II injuries without systemic administration Moderate tear, chro
This comparison does not assign a generated winner or score.
- Mild sprain, partial tear
- 250mcg daily
- Once daily
- Subcutaneous, <1cm from injury
- 3-4 weeks
- 50-60% reduction in recovery time versus unassisted healing
- Lowest effective dose; sufficient for grade I-II injuries without systemic administration
- Moderate tear, chronic tendinopathy
- 350-400mcg daily
- Split twice daily (12hr intervals)
- Subcutaneous, injury-adjacent
- 4-6 weeks
- Accelerated proliferative phase; tissue quality improvement measurable on ultrasound by week 4
- Twice-daily dosing maintains stable plasma levels; critical for injuries with poor vascular supply
- Severe rupture, post-surgical repair
- 500mcg daily
- 250mcg twice daily (12hr intervals)
- Subcutaneous at multiple sites around injury
- 6-8 weeks
- 20-30% faster return to load-bearing; improved collagen organisation on imaging
- Maximum validated dose; higher doses show no additional benefit in animal models; requires strict injection hygiene
- Maintenance/prevention (chronic condition)
- 150-200mcg daily
- Once daily, 5 days per week
- Systemic (abdomen or thigh subcutaneous)
- Ongoing, 2 weeks on / 1 week off
- Reduction in flare frequency for chronic conditions like Achilles tendinosis
- Lower dose for long-term use; not for acute healing but for managing degenerative conditions
- The comparison shows dose escalation correlates with injury severity, not researcher preference. Starting at 500mcg for a mild ankle sprain wastes peptide and increases injection site reaction risk without improving outcomes.